Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Low-Grade Serous Ovarian Cancer × defactinib × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 5 Glioblastoma 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Phase IB 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Melanoma 1 Lung Neoplasms 1 Low-Grade Serous Ovarian Cancer 1 Low Grade Serous Ovarian Cancer 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Endometrioid 1 Brain Neoplasms 1 Advanced Colorectal Cancer 1 Adenocarcinoma of Lung 1

Interventions

defactinib 1 Letrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06394804 2026-02-03

CHAMELEON

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting

Low-Grade Serous Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡